L-Mind: A safety and efficacy analysis of tafasitamab in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) receiving treatment for at least 2 years Meeting Abstract
| Authors: | Duell, J.; Jurczak, W.; Liberati, A. M.; Halka, J.; Pena Carbó, E.; Abrisqueta Costa, P.; Maddocks, K. J.; Dreyling, M.; Rosenwald, A.; Bakuli, A.; Amin, A.; Gurbanov, K.; Salles, G. |
| Abstract Title: | L-Mind: A safety and efficacy analysis of tafasitamab in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) receiving treatment for at least 2 years |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 6596 |
| End Page: | 6598 |
| Language: | English |
| ACCESSION: | WOS:000893223206273 |
| DOI: | 10.1182/blood-2022-159983 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
